Gonzalo Rodríguez-Berriguete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gonzalo Rodríguez-Berriguete has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Benito Fraile
2 shared publicationsMar Royuela
2 shared publicationsRicardo Paniagua
2 shared publications- Angela Prieto-Folgado
Department of Cell Biology and Genetics. University of Alcalá; 28871 Alcalá de Henares. Madrid, Spain
1 shared publication - Benito Fraile
Department of Biomedicine and Biotechnology, University of Alcalá, Spain
1 shared publication - Bruna Prati
Department of Cell Biology and Genetics. University of Alcalá; 28871 Alcalá de Henares. Madrid, Spain
1 shared publication
Latest Publications
- 1 February 2012
- Published by Elsevier in Human Pathology
- Vol. 43 (2) , 229-237
Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors
- 1 February 2012
- Published by Elsevier in Human Pathology
- Vol. 43 (2) , 229-237
Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors
- 25 April 2011
- Published by Wiley in The Prostate
- Vol. 72 (1) , 40-50
Expression of NF‐κB‐related proteins and their modulation during TNF‐α‐provoked apoptosis in prostate cancer cells
BACKGROUND: The involvement of TNF‐α in cancer development is controversial, since this cytokine was reported to act either as tumor promoter or suppressor. TNF‐α may activate signaling pathways critical for life/death decisions, such as mitogen‐activated protein kinases (MAPKs) and the anti‐apoptotic NF‐κB pathway. In this work, we investigate the activation status of NF‐κB‐related proteins in human prostate cancerous versus normal epithelium, and the alterations in the NF‐κB pathway in relation to cell death in TNF‐α‐treated LNCaP (androgen‐independent cells) and PC3 (androgen‐independent) prostate cancer cell lines.METHODS: The expression of phospho‐p38‐MAPK, phospho‐IKK‐α/β and phospho‐IκB‐α, total IκB‐α, and p65‐ and p50‐NF‐κB, were analyzed by immunohistochemistry in cancerous and normal prostate samples. The toxicity of TNF‐α in LNCaP and PC3 cells, with or without kinase and NF‐κB inhibitors, was assessed by changes on viability (MTT assay) and apoptosis (loss of DNA, annexin‐V binding, and caspase cleavage/activation). Expression of NF‐κB‐related proteins in these cell lines was measured by Western blot.RESULTS: Phospho‐IκB‐α, phospho‐IKK‐α/β and phospho‐p38 levels, cytoplasmic p50 to IκB‐α ratio, and nuclear p50 and p65, levels, were increased in cancerous epithelium, suggesting activation of the NF‐κB pathway in prostatic malignance. TNF‐α caused apoptosis with higher efficacy in LNCaP cells, and this response was potentiated by p38‐MAPK inhibitor (LNCaP cells) and IKK‐β inhibitor (both cell lines). However, the protective action of IKK‐β was mediated by NF‐κB only in LNCaP cells.CONCLUSIONS: IKK‐β mediates both NF‐κB‐dependent and ‐independent anti‐apoptotic functions in prostate cancerous epithelium. IKK‐β and p38‐MAPK may represent useful therapeutic targets against prostate cancer. Prostate 72:40–50, 2012.
- 25 April 2011
- Published by Wiley in The Prostate
- Vol. 72 (1) , 40-50
Expression of NF‐κB‐related proteins and their modulation during TNF‐α‐provoked apoptosis in prostate cancer cells
BACKGROUND: The involvement of TNF‐α in cancer development is controversial, since this cytokine was reported to act either as tumor promoter or suppressor. TNF‐α may activate signaling pathways critical for life/death decisions, such as mitogen‐activated protein kinases (MAPKs) and the anti‐apoptotic NF‐κB pathway. In this work, we investigate the activation status of NF‐κB‐related proteins in human prostate cancerous versus normal epithelium, and the alterations in the NF‐κB pathway in relation to cell death in TNF‐α‐treated LNCaP (androgen‐independent cells) and PC3 (androgen‐independent) prostate cancer cell lines.METHODS: The expression of phospho‐p38‐MAPK, phospho‐IKK‐α/β and phospho‐IκB‐α, total IκB‐α, and p65‐ and p50‐NF‐κB, were analyzed by immunohistochemistry in cancerous and normal prostate samples. The toxicity of TNF‐α in LNCaP and PC3 cells, with or without kinase and NF‐κB inhibitors, was assessed by changes on viability (MTT assay) and apoptosis (loss of DNA, annexin‐V binding, and caspase cleavage/activation). Expression of NF‐κB‐related proteins in these cell lines was measured by Western blot.RESULTS: Phospho‐IκB‐α, phospho‐IKK‐α/β and phospho‐p38 levels, cytoplasmic p50 to IκB‐α ratio, and nuclear p50 and p65, levels, were increased in cancerous epithelium, suggesting activation of the NF‐κB pathway in prostatic malignance. TNF‐α caused apoptosis with higher efficacy in LNCaP cells, and this response was potentiated by p38‐MAPK inhibitor (LNCaP cells) and IKK‐β inhibitor (both cell lines). However, the protective action of IKK‐β was mediated by NF‐κB only in LNCaP cells.CONCLUSIONS: IKK‐β mediates both NF‐κB‐dependent and ‐independent anti‐apoptotic functions in prostate cancerous epithelium. IKK‐β and p38‐MAPK may represent useful therapeutic targets against prostate cancer. Prostate 72:40–50, 2012.
- Open Access
- 15 January 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 18
Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate
Background: In this study was investigate IAPs in normal human prostate (NP), benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN) and prostatic carcinoma (PC), and their involvement in apoptosis/proliferation via NF-kB (TNF-α, IL-1) stimulation.Methods: Immunohistochemical and Western blot analyses were performed in 10 samples of normal prostates, 35 samples of BPH, 27 samples diagnosis of PIN (with low-grade PIN or high-grade PIN) and 95 samples of PC (with low, medium or high Gleason grades).Results: In NP, cytoplasm of epithelial cells were positive to c-IAP1/2 (80% of samples), c-IAP-2 (60%), ILP (20%), XIAP (20%); negative to NAIP and survivin. In BPH, epithelial cells were immunostained to c-IAP1/2 (57.57%), c-IAP-2 (57.57%), ILP (66.6%), NAIP (60.6%), XIAP (27.27%), survivin (9.1%). Whereas low-grade PIN showed intermediate results between NP and BPH; results in high-grade PIN were similar to those found in PC. In PC, epithelial cells were immunostained to c-IAP1/2, c-IAP-2, ILP, NAIP, XIAP (no Gleason variation) and survivin (increasing with Gleason).Conclusions: IAPs could be involved in prostate disorder (BPH, PIN and PC) development since might be provoke inhibition of apoptosis and subsequently cell proliferation. At the same time, different transduction pathway such as IL-1/NIK/NF-kB or TNF/NF-kB (NIK or p38) also promotes proliferation. Inhibitions of IAPs, IL-1α and TNFα might be a possible target for PC treatment since IAPs are the proteins that inhibited apoptosis (favour proliferation) and IL-1α and TNFα would affect all the transduction pathway involucrate in the activation of transcription factors related to survival or proliferation (NF-kB, Elk-1 or ATF-2).
- 15 January 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 18
Open AccessRole of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate
Background: In this study was investigate IAPs in normal human prostate (NP), benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN) and prostatic carcinoma (PC), and their involvement in apoptosis/proliferation via NF-kB (TNF-α, IL-1) stimulation.Methods: Immunohistochemical and Western blot analyses were performed in 10 samples of normal prostates, 35 samples of BPH, 27 samples diagnosis of PIN (with low-grade PIN or high-grade PIN) and 95 samples of PC (with low, medium or high Gleason grades).Results: In NP, cytoplasm of epithelial cells were positive to c-IAP1/2 (80% of samples), c-IAP-2 (60%), ILP (20%), XIAP (20%); negative to NAIP and survivin. In BPH, epithelial cells were immunostained to c-IAP1/2 (57.57%), c-IAP-2 (57.57%), ILP (66.6%), NAIP (60.6%), XIAP (27.27%), survivin (9.1%). Whereas low-grade PIN showed intermediate results between NP and BPH; results in high-grade PIN were similar to those found in PC. In PC, epithelial cells were immunostained to c-IAP1/2, c-IAP-2, ILP, NAIP, XIAP (no Gleason variation) and survivin (increasing with Gleason).Conclusions: IAPs could be involved in prostate disorder (BPH, PIN and PC) development since might be provoke inhibition of apoptosis and subsequently cell proliferation. At the same time, different transduction pathway such as IL-1/NIK/NF-kB or TNF/NF-kB (NIK or p38) also promotes proliferation. Inhibitions of IAPs, IL-1α and TNFα might be a possible target for PC treatment since IAPs are the proteins that inhibited apoptosis (favour proliferation) and IL-1α and TNFα would affect all the transduction pathway involucrate in the activation of transcription factors related to survival or proliferation (NF-kB, Elk-1 or ATF-2).